Suketu Upadhyay informed the board of directors (the "Board") of Vertex Pharmaceuticals Incorporated (the "Company") of his decision not to stand for re-election as a director of the Company at the Company’s 2026 annual meeting of shareholders (the "2026 Annual Meeting").
the board of directors of each of the Company and Hawthorn Bank increased their respective sizes by one member, and appointed Grant T. Burcham to serve on both the Company's and Hawthorn Bank's board of directors to fill such newly created vacancies, in each case, effective April 29, 2026.
On April 24, 2026, the board of directors (the “Board”) of Forward Air Corporation (the “Company”) received notice from Charles L. Anderson and Robert L. Edwards, Jr. that each will not be standing for re-election at the Company’s annual meeting of stockholders to be held on June 17, 2026 (the “2026 Annual Meeting”).
On April 24, 2026, the board of directors (the “Board”) of Forward Air Corporation (the “Company”) received notice from Charles L. Anderson and Robert L. Edwards, Jr. that each will not be standing for re-election at the Company’s annual meeting of stockholders to be held on June 17, 2026 (the “2026 Annual Meeting”).
On April 13, 2026, Southern Copper Corporation (the "Company") announced with deep regret the unexpected passing of Oscar Gonzalez Rocha, the Company’s President, Chief Executive Officer, and Board member.
On April 24, 2026, both William R. Jellison, a Class I member of the Board of Directors (the "Board") of the Company, and Glenn R. Larsen, Ph.D., a Class II member of the Board, notified the Board of their resignation from the Board, including from all committees on which each serves effective as of the Company's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
On April 24, 2026, both William R. Jellison, a Class I member of the Board of Directors (the "Board") of the Company, and Glenn R. Larsen, Ph.D., a Class II member of the Board, notified the Board of their resignation from the Board, including from all committees on which each serves effective as of the Company's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
Effective April 24, 2026, the Board of Directors of the Company (the "Board") appointed Marc James to serve as a Class II Director of the Board for the remainder of the term of Class II Directors of the Board, expiring at the 2026 Annual Meeting of Shareholders of the Company.
Effective July 1, 2026, Matthew K. Smith will become Chief Executive Officer and President of the Company and its subsidiary, First Mid Bank & Trust, N.A., and will be appointed to the Company’s Board of Directors (the “Board”).
In connection with the succession plan, Joseph R. Dively will transition from Chief Executive Officer to Executive Chair of the Company and remain Chairman of the Board.
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
On April 23, 2026, Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of Directors (the "Board") of MapLight Therapeutics, Inc. (the "Company") of their respective decisions not to stand for reelection at the Company’s Annual Meeting of Stockholders to be held on June 23, 2026.
On April 23, 2026, Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of Directors (the "Board") of MapLight Therapeutics, Inc. (the "Company") of their respective decisions not to stand for reelection at the Company’s Annual Meeting of Stockholders to be held on June 23, 2026.
In connection with the appointment, John Allen will cease serving as the Company’s Interim Chief Financial officer, effective as of the same date, and will continue to serve as the Company’s Vice President, Accounting and Chief Accounting Officer.
The Board of Directors (the “Board”) of Rambus Inc. (“Rambus” or the “Company”) has appointed Sumeet Gagneja as the Senior Vice President and Chief Financial Officer of the Company, effective April 29, 2026, reporting to Luc Seraphin, Chief Executive Officer of the Company.
On April 27, 2026, in connection with the IPO, William Sherman was appointed to the board of directors of the Company (the “ Board ”) effective April 28, 2026.
the Board increased the authorized number of directors to five and appointed Lazar to the Board to fill the vacancy created by such increase, effective immediately
Bharat Vasan notified the Board of Directors of Starco Brands, Inc. (the “Company”), that he resigns from the Board of Directors, effective April 27, 2026.
Effective April 29, 2026, the Company and TWNP each appointed Keshav Lall as its interim Chief Executive Officer, filling in for the former Chief Executive Officer who remains on a leave of absence pursuant to the Amended and Restated Stipulation and Agreed Order Regarding Mediated Agreement [Docket No. 472].
On April 23, 2026, Neeraj Agrawal notified the Board that he will not stand for re-election as a Class II director of the Company at the 2026 Annual Meeting.
On April 23, 2026, Yvette Kanouff notified the board of directors (the “Board”) of Sprinklr, Inc. (the “Company”) that she will not stand for re-election as a Class II director of the Company at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).
On April 24, 2026, Jodi Devlin provided notice to TriSalus Life Sciences, Inc. (the “Company”) of her intention to retire from her role as Chief of Clinical Operations, effective October 1, 2026.
As previously announced on April 7, 2026, the Company appointed Dr. Richard Marshall to Chief Medical Officer of the Company, effective June 29, 2026.
Departed
Elda de la Peña
Chief Administrative Officer and Chief Human Resources Officer
Tri-State Generation & Transmission Association, Inc.
Effective
2026-12-01
Filed
April 29, 2026, 7:59 PM ET
On April 27, 2026, Tri-State Generation and Transmission Association, Inc. (“Tri-State”) received notice from its Chief Administrative Officer and Chief Human Resources Officer, Elda de la Peña, that she intends to retire in December 2026 after more than 29 years of service with Tri-State.
Departed
Diane Schnupp
Executive Vice President and Chief Information Officer
On April 29, 2026, Diane Schnupp, Executive Vice President and Chief Information Officer of Kinsale Capital Group, Inc. (the “Company”), notified the Company of her intent to retire from the Company.
On April 28, 2026, the Board of Directors approved the appointment of Lindsey Wiedmann as Chief Legal and Compliance Officer, effective upon Mr. Ledesma’s retirement.
On April 23, 2026, Bruce Ledesma, the Chief Legal and Compliance Officer of Nextpower Inc. (the “Company”) informed the Company that he will retire effective July 17, 2026.
The Board of Directors of Commerce Bancshares, Inc. (“Company”) approved the Company's appointment of Steven A. Brandjord in the role of Corporate Controller and Chief Accounting Officer, effective May 15, 2026.
the Company also announced that it appointed De’Mon L. Wiggins, the current Executive Vice President and President, Flow and Water Solutions of the Company, as the Company’s Executive Vice President and President, Flow, Water Solutions and Pool, effective as of April 28, 2026.
Departed
Jerome O. Pedretti
Executive Vice President and Chief Executive Officer, Pool
Jerome O. Pedretti, the Executive Vice President and Chief Executive Officer, Pool of Pentair plc (the “Company”), elected to resign from the Company effective as of July 1, 2026.
On April 28, 2026, PPG Industries, Inc. (the “Company”) issued a press release announcing that Jamie A. Beggs will join the Company as Senior Vice President and Chief Financial Officer, effective July 6, 2026 upon the previously reported retirement of Vincent J. Morales which will also be effective July 6, 2026.
On April 28, 2026, PPG Industries, Inc. (the “Company”) issued a press release announcing that Jamie A. Beggs will join the Company as Senior Vice President and Chief Financial Officer, effective July 6, 2026 upon the previously reported retirement of Vincent J. Morales which will also be effective July 6, 2026.
Departed
Marianna Tessel
Executive Vice President and General Manager, Small Business Group
Ashley Still, Executive Vice President and General Manager, Mid-Market Group, will expand her role to lead both the Mid-Market Group and the Small Business Group.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.